Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Tsaur

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Medicine|December 29, 2015
Amygdalin inhibits the growth of renal cell carcinoma cells in vitroEva Juengel, Anita Thomas, Jochen Rutz, et al.
The Journal of Urology|April 20, 2016
R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected CohortHendrik Borgmann, Ann-Kathrin Reiss, Martin Kurosch, et al.
Anti-Cancer Drugs|August 9, 2011
HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitroStefan Vallo, Wang Xi, Lukasz Hudak, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Urologia Internationalis|March 8, 2021
Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections DecreaseHendrik Borgmann, Katharina Boehm, Maximilian Peter Brandt, et al.
European Urology Focus|January 10, 2026
Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and OutcomesRadion Garaz, Mahmoud Ziada, Jack Crozier, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Challenges in Diagnosis of Uretero-Arterial Fistulas after Complex Pelvic Oncological Procedures-Single Center Experience and Review of the LiteratureCristian Surcel, Cristian Mirvald, Robert Stoica, et al.
Urologia Internationalis|June 20, 2024
Ex vivo Study of Partial Bladder Resection in a Porcine ModelAleksander Kielbik, Timo Hoffmans, Bastian Amend, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Medicine|December 29, 2015
Amygdalin inhibits the growth of renal cell carcinoma cells in vitroEva Juengel, Anita Thomas, Jochen Rutz, et al.
The Journal of Urology|April 20, 2016
R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected CohortHendrik Borgmann, Ann-Kathrin Reiss, Martin Kurosch, et al.
Anti-Cancer Drugs|August 9, 2011
HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitroStefan Vallo, Wang Xi, Lukasz Hudak, et al.
Life Sciences|January 4, 2011
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Urologia Internationalis|March 8, 2021
Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections DecreaseHendrik Borgmann, Katharina Boehm, Maximilian Peter Brandt, et al.
European Urology Focus|January 10, 2026
Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and OutcomesRadion Garaz, Mahmoud Ziada, Jack Crozier, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Challenges in Diagnosis of Uretero-Arterial Fistulas after Complex Pelvic Oncological Procedures-Single Center Experience and Review of the LiteratureCristian Surcel, Cristian Mirvald, Robert Stoica, et al.
Urologia Internationalis|June 20, 2024
Ex vivo Study of Partial Bladder Resection in a Porcine ModelAleksander Kielbik, Timo Hoffmans, Bastian Amend, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
Pageof 20